check out original content and videos published every day to help you learn about the issues that mean the most to you...

.

fda commissioner: it�s not a secret, sir. many experts know about it..

mainstream reporters and editors and publishers are well aware that telling the truth and continuing to pound on it would undermine a basic institution of society..

.

eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention...

andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment.